Chris Viehbacher

President and CEO, Biogen

Cambridge, Massachusetts

About

Chris Viehbacher is President and Chief Executive Officer of Biogen, a biotechnology company based in Cambridge, Massachusetts. He joined Biogen in November 2022 as chief executive and is also a member of its board of directors. Before Biogen he was global chief executive of Sanofi from 2008 to 2014 and a managing partner of the Boston-based investment fund Gurnet Point Capital from 2015 to 2022. His formal name in company materials is Christopher A. Viehbacher.

Viehbacher graduated from Queen's University in Kingston, Ontario, Canada, with a Bachelor of Commerce degree. He began his career at PricewaterhouseCoopers and later worked at GlaxoSmithKline before becoming chief executive of Sanofi. Biogen's proxy statement also lists him as a trustee of Northeastern University and a member of the Board of Fellows of Stanford Medical School. Other drug and biotechnology leaders with pages on Whoo include Vertex's Reshma Kewalramani and Gilead's Daniel O’Day.

Whoo compiled this page from public sources: SEC, Biogen 2026 proxy statement, Biogen leadership page, Wikipedia, SEC, Biogen October 2026 results release. It is not affiliated with or endorsed by Chris Viehbacher. Are you Chris Viehbacher? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

President and Chief Executive Officer — Biogen


2022 – Present

  • Chief executive and board member since November 2022
  • Managing Partner — Gurnet Point Capital


    2015 – 2022

  • Boston-based investment fund focused on healthcare
  • Global Chief Executive Officer — Sanofi


    2008 – 2014

    Earlier roles

  • Various roles at GlaxoSmithKline

  • Began his career at PricewaterhouseCoopers

Education

B.Comm. — Queen's University, Kingston, Ontario

Projects